Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Gunnar Tepe , Bruno Scheller , Ulrich Speck Added: 3 years ago
Percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) are established, proven methods for re-opening stenotic or occluded arteries in a minimally invasive way. The balloon is placed in the stenotic segment of the artery and then expanded until the lumen reaches its original diameter. To this end, very high pressure (up to 15 bar) is applied, which… View more
Author(s): Jason H Rogers , John R Laird Added: 3 years ago
Critical limb ischaemia (CLI) is defined as ischaemic rest pain requiring opiate analgesics, and ulceration or gangrene of the foot or toes attributable to arterial occlusive disease.1 In contrast to patients with claudication, those with CLI have resting arterial perfusion that is inadequate to sustain the metabolic demands of the distal bed. CLI has been formally graded within the current… View more
Author(s): David Smith , Ahmed Hailan , Alexander Chase Added: 3 years ago
Radial vs Femoral Access In recent years several large registries and randomised controlled trials have demonstrated a mortality benefit for trans-radial over trans-femoral percutaneous coronary intervention (PCI), likely mediated by reduced bleeding complications.1–4 Building on the pioneering Japanese experience, the advent of the hybrid algorithim approach, coupled with innovative new… View more
Author(s): Jubin Joseph , Tiffany Patterson , Satpal Arri , et al Added: 3 years ago
Cardiogenic shock is a clinical condition of inadequate end-organ perfusion due to cardiac dysfunction (see Table 1). It most commonly occurs in the setting of acute MI with left ventricular failure (~80 % cases),1,2 but can also be caused by right ventricular infarction or late mechanical complications, such as acute mitral regurgitation or ventricular rupture (septal or free wall). Non-infarct… View more
Author(s): Upul Wickramarachchi , Simon Eccleshall Added: 3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These… View more
Author(s): Robert Yeh Added: 5 months ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more
Author(s): Giancarlo Marenzi , Antonio L Bartorelli Added: 3 years ago
Primary angioplasty represents the best available strategy for treatment of ST-segment elevation myocardial infarction (STEMI).1 However, its application in patients with chronic kidney disease is particularly problematic and not well characterised. One of the main reasons for this is that such patients have typically been excluded from clinical trials evaluating the outcome of coronary… View more
Author(s): Ronan Ali , Adam B Greenbaum , Aaron D Kugelmass Added: 3 years ago
Abstract The basic equipment involved in percutaneous coronary interventions - guiding catheters, guide wires and dilation catheters (balloons) - have undergone significant evolution which has allowed for improvements in procedural success and safety. The coronary interventionalist should possess a thorough working knowledge of the available equipment and the ability to select specific equipment… View more